Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Groupe Français D'étude Des Maladies Inflammatoires De Loeil

Clinical trials sponsored by Groupe Français D'étude Des Maladies Inflammatoires De Loeil, explained in plain language.

Not yet recruiting 1

New hope for rare artery disease: upadacitinib under observation

Disease control Not yet recruiting

This study looks at how well the drug upadacitinib works for people with giant cell arteritis (GCA), a condition that causes inflammation in large blood vessels. About 80 adults with active GCA will be observed during their regular care to see if the drug helps control the diseas…

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Disease control

Last updated May 08, 2026 12:03 UTC